Literature DB >> 15571961

Gender and age-related differences in Burkitt lymphoma--epidemiological and clinical data from The Netherlands.

E G Boerma1, G W van Imhoff, I M Appel, N J G M Veeger, Ph M Kluin, J C Kluin-Nelemans.   

Abstract

Although Burkitt's lymphoma (BL) is classified as one entity in the World Health Organisation (WHO) classification, we wondered whether BL should not be considered as a different disease in children compared with adults. Netherlands Cancer Registry (NCR) data were obtained from 1994 to 1998 (n=203). Detailed clinical data from two treatment protocols were compared: one for adults up to the age of 65 years (n=27) and one for children (n=80). All slides of the two clinical studies were centrally reviewed which included immunophenotyping and when necessary breakpoint analysis of MYC/8q24. Only cases with an unambiguous diagnosis of BL (classical and atypical BL) were accepted. The age distribution of BL-patients showed a bimodal distribution with a peak at the paediatric age and a steady increase after approximately 60 years of age. Most of the patients were males (89% for children and 78% for adults) and only male patients showed this bimodality. Children more often had extranodal disease (81% vs. 59%), whereas adults more often had nodal disease (89% vs. 53%). Based on epidemiology and clinical presentation, the concept that BL is one disease should be re-challenged.

Entities:  

Mesh:

Year:  2004        PMID: 15571961     DOI: 10.1016/j.ejca.2004.09.004

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  25 in total

1.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

Authors:  Lindsay M Morton; Sophia S Wang; Susan S Devesa; Patricia Hartge; Dennis D Weisenburger; Martha S Linet
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

2.  Burkittts lymphoma revisited: series of three cases with varied clinical presentation.

Authors:  Tathagat Chatterjee; Devika Gupta; Reena Bharadwaj; Renu Madan
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-28       Impact factor: 0.900

3.  Secondary Acute Lymphoblastic Leukemia after Hodgkin's Lymphoma or a Coincidental Association of Two Hematological Malignancies?

Authors:  Mihaela Tevet; Cornel Dragan; Carmen Saguna; Doina Barbu; Anca Roxana Lupu
Journal:  Maedica (Buchar)       Date:  2013-09

4.  Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences.

Authors:  Yasin Kaymaz; Cliff I Oduor; Hongbo Yu; Juliana A Otieno; John Michael Ong'echa; Ann M Moormann; Jeffrey A Bailey
Journal:  Mol Cancer Res       Date:  2017-05       Impact factor: 5.852

5.  Disease patterns of pediatric non-Hodgkin lymphoma: A study from a developing area in Egypt.

Authors:  Laila M Sherief; Usama R Elsafy; Elhamy R Abdelkhalek; Naglaa M Kamal; Doaa M Youssef; Rabab Elbehedy
Journal:  Mol Clin Oncol       Date:  2014-09-24

6.  Disorders of sex development expose transcriptional autonomy of genetic sex and androgen-programmed hormonal sex in human blood leukocytes.

Authors:  Paul-Martin Holterhus; Jan-Hendrik Bebermeier; Ralf Werner; Janos Demeter; Annette Richter-Unruh; Gunnar Cario; Mahesh Appari; Reiner Siebert; Felix Riepe; James D Brooks; Olaf Hiort
Journal:  BMC Genomics       Date:  2009-07-01       Impact factor: 3.969

7.  Medical history, lifestyle, family history, and occupational risk factors for sporadic Burkitt lymphoma/leukemia: the Interlymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Sam M Mbulaiteye; Lindsay M Morton; Joshua N Sampson; Ellen T Chang; Laura Costas; Silvia de Sanjosé; Tracy Lightfoot; Jennifer Kelly; Jonathan W Friedberg; Wendy Cozen; Rafael Marcos-Gragera; Susan L Slager; Brenda M Birmann; Dennis D Weisenburger
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

Review 8.  Treatment of adolescents with aggressive B-cell malignancies: the pediatric experience.

Authors:  Jonas Lange; Birgit Burkhardt
Journal:  Curr Hematol Malig Rep       Date:  2013-09       Impact factor: 3.952

9.  Burkitt lymphoma in Brazil is characterized by geographically distinct clinicopathologic features.

Authors:  Eduardo M Queiroga; Gabriela Gualco; Lawrence M Weiss; Dirk P Dittmer; Iguaracyra Araujo; Claudette E N Klumb; William J Harrington; Carlos E Bacchi
Journal:  Am J Clin Pathol       Date:  2008-12       Impact factor: 2.493

10.  Biologic features and treatment outcome of secondary acute lymphoblastic leukemia--a review of 101 cases.

Authors:  R Shivakumar; W Tan; G E Wilding; E S Wang; M Wetzler
Journal:  Ann Oncol       Date:  2008-05-07       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.